Gain detailed insights into the trading activity of Congress members for Merck on our government trades page. Stay updated on how elected officials are investing in MKKGY.

Merck - Government Trades

Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (44% of 2023 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (38%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (17%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Rueil-malmaison,,France,-,August,13,,2023:,Exterior,View,Of,The

Biotech

Large Cap

News

Health Care

General

MKGAF

MKKGY

GSK&#39;s $1 billion acquisition of IDRx includes IDRX-42, a precision therapy for GIST. Phase 1/1b trial shows 53% ORR in early treatment stages.

GSK To Buy US-Based Stomach Cancer Drug Developer For Over $1 Billion

Equities

Markets

Movers

SGEN

Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition

Merck Germany&#39;s Two Pivotal Trials Flunk In Multiple Sclerosis

Analyst Color

Analyst Ratings

Trading Ideas

RGEN

Repligen Corporation (NASDAQ: RGEN) agreed to acquire Sweden-based privately-held Metenova. 

Life Sciences Player Repligen&#39;s Strategic European Acquisition - What It Means for Investors

Earnings

Guidance

Merck KGa Germany (OTC: MKGAF) (OTC: MKKGY) reported 

Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023

Government

REGN

RHHBF

RHHBY

RHHVF

TEVA

The World Health Organization (WHO) published the new editions of the Model Lists of Essential Medicines (EML) and Essen

Novo Nordisk&#39;s Obesity Drug Saxenda Not Included In WHO&#39;s Essential Drug List

Downgrades

ABCM

RVTY

TECH

RBC Capital Markets has downgraded Abcam PLC (NASDAQ: ABCM) from Outperform to Sector Perform with a price target of $22, 

Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation

Penny Stocks

NKTR

Analyst Says Nektar Therapeutics&#39; Rezpeg Prioritization Likely to Spark Investor Questions

FDA Issues Partial Clinical Hold On Merck Germany&#39;s Multiple Sclerosis Study

Contracts

Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer

Merck KGaA

Deep-pocketed investors have adopted a bearish approach towards MARA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in MARA usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 50 extraordinary options activities for MARA Holdings. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 42% leaning bullish and 50% bearish. Among these notable options, 6 are puts, totaling $377,783, and 44 are calls, amounting to $3,067,080.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $9.0 to $50.0 for MARA Holdings over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for MARA Holdings's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of MARA Holdings's whale activity within a strike price range from $9.0 to $50.0 in the last 30 days. 
<h3>MARA Holdings 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738007127_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$7.6</td>
<td>$7.5</td>
<td>$7.5</td>
<td>$11.00</td>
<td>$500.2K</td>
<td>1.5K</td>
<td>752</td>
</tr>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$0.83</td>
<td>$0.82</td>
<td>$0.83</td>
<td>$22.00</td>
<td>$165.8K</td>
<td>407</td>
<td>2.1K</td>
</tr>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/28/25</td>
<td>$8.3</td>
<td>$8.15</td>
<td>$8.2</td>
<td>$10.00</td>
<td>$164.8K</td>
<td>908</td>
<td>503</td>
</tr>
<tr>
<td>MARA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/28/25</td>
<td>$8.3</td>
<td>$7.65</td>
<td>$8.2</td>
<td>$10.00</td>
<td>$164.8K</td>
<td>908</td>
<td>302</td>
</tr>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$15.2</td>
<td>$14.9</td>
<td>$15.2</td>
<td>$30.00</td>
<td>$152.0K</td>
<td>2.5K</td>
<td>200</td>
</tr>
</tbody>
</table>

<h3>About MARA Holdings</h3>
MARA Holdings Inc leverages digital asset compute to support the energy transformation. It secures the blockchain ledger and supports the energy transformation by converting clean, stranded, or underutilized energy into economic value.
In light of the recent options history for MARA Holdings, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of MARA Holdings</h3>
<ul>
<li>Currently trading with a volume of 32,641,995, the MARA's price is down by -10.66%, now at $17.86. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 30 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for MARA Holdings with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

MARA

MARA Holdings Unusual Options Activity For January 27

Deep-pocketed investors have adopted a bearish approach towards Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CVNA usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 48 extraordinary options activities for Carvana. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 31% leaning bullish and 45% bearish. Among these notable options, 31 are puts, totaling $1,461,161, and 17 are calls, amounting to $3,204,359.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $390.0 for Carvana, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Carvana options trades today is 879.46 with a total volume of 14,343.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Carvana's big money trades within a strike price range of $30.0 to $390.0 over the last 30 days.
<h3>Carvana 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738007121_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$21.0</td>
<td>$20.3</td>
<td>$20.65</td>
<td>$240.00</td>
<td>$1.0M</td>
<td>2.6K</td>
<td>629</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/07/25</td>
<td>$5.1</td>
<td>$4.6</td>
<td>$4.85</td>
<td>$250.00</td>
<td>$498.5K</td>
<td>3.0K</td>
<td>2.2K</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$5.5</td>
<td>$4.8</td>
<td>$4.85</td>
<td>$250.00</td>
<td>$436.8K</td>
<td>3.0K</td>
<td>1.0K</td>
</tr>
<tr>
<td>CVNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/31/25</td>
<td>$29.15</td>
<td>$26.2</td>
<td>$27.6</td>
<td>$215.00</td>
<td>$276.0K</td>
<td>5.0K</td>
<td>101</td>
</tr>
<tr>
<td>CVNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$23.95</td>
<td>$23.6</td>
<td>$23.6</td>
<td>$240.00</td>
<td>$236.0K</td>
<td>378</td>
<td>171</td>
</tr>
</tbody>
</table>

<h3>About Carvana</h3>
Carvana Co is an e-commerce platform for buying and selling used cars. The company derives revenue from used vehicle sales, wholesale vehicle sales and other sales and revenues. The other sales and revenues include sales of loans originated and sold in securitization transactions or to financing partners, commissions received on VSCs and sales of GAP waiver coverage. The foundation of the business is retail vehicle unit sales. This drives the majority of the revenue and allows the company to capture additional revenue streams associated with financing, VSCs, auto insurance and GAP waiver coverage, as well as trade-in vehicles.
Following our analysis of the options activities associated with Carvana, we pivot to a closer look at the company's own performance.
<h3>Current Position of Carvana</h3>
<ul>
<li>Currently trading with a volume of 1,280,876, the CVNA's price is down by -0.1%, now at $240.23. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 23 days.</li>
</ul>
<h3>Professional Analyst Ratings for Carvana</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $292.4.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Carvana with a target price of $275. 
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $330. 
&#x2A; An analyst from RBC Capital upgraded its action to Outperform with a price target of $280. 
&#x2A; Showing optimism, an analyst from Citigroup upgrades its rating to Buy with a revised price target of $277. 
&#x2A; Reflecting concerns, an analyst from Stephens &amp; Co. lowers its rating to Overweight with a new price target of $300.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Carvana with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

CVNA

A Closer Look at Carvana's Options Market Dynamics

Investors with a lot of money to spend have taken a bearish stance on Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AMGN, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 28 uncommon options trades for Amgen.
This isn't normal.
The overall sentiment of these big-money traders is split between 39% bullish and 46%, bearish.
Out of all of the special options we uncovered, 5 are puts, for a total amount of $346,174, and 23 are calls, for a total amount of $1,767,629.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $200.0 and $320.0 for Amgen, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Amgen stands at 415.42, with a total volume reaching 85,793.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Amgen, situated within the strike price corridor from $200.0 to $320.0, throughout the last 30 days.
<h3>Amgen Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738007116_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$2.05</td>
<td>$1.95</td>
<td>$2.0</td>
<td>$295.00</td>
<td>$351.2K</td>
<td align="right">358</td>
<td>8.5K</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$2.36</td>
<td>$2.11</td>
<td>$2.15</td>
<td>$295.00</td>
<td>$217.4K</td>
<td align="right">358</td>
<td>10.6K</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$2.5</td>
<td>$2.26</td>
<td>$2.3</td>
<td>$295.00</td>
<td>$182.5K</td>
<td align="right">358</td>
<td>11.7K</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$34.45</td>
<td>$32.3</td>
<td>$32.9</td>
<td>$270.00</td>
<td>$164.6K</td>
<td align="right">65</td>
<td>50</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$2.0</td>
<td>$1.98</td>
<td>$2.0</td>
<td>$295.00</td>
<td>$140.0K</td>
<td align="right">358</td>
<td>3.0K</td>
</tr>
</tbody>
</table>

<h3>About Amgen</h3>
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Following our analysis of the options activities associated with Amgen, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Amgen</h3>
<ul>
<li>With a trading volume of 1,963,688, the price of AMGN is up by 2.63%, reaching $282.66.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 8 days from now.</li>
</ul>
<h3>What The Experts Say On Amgen</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $303.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Amgen, which currently sits at a price target of $280. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Amgen with a target price of $310. 
&#x2A; An analyst from Truist Securities has decided to maintain their Hold rating on Amgen, which currently sits at a price target of $298. 
&#x2A; Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $324.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Amgen with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

AMGN

This Is What Whales Are Betting On Amgen

Goldman Sachs analyst James Schneider maintained a Buy rating on AT&amp;T Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>) with a <a target="_blank" href="https://www.benzinga.com/quote/T/analyst-ratings" rel="noreferrer noopener">price target of $28</a>.
Schneider expects the stock to trade modestly higher following in-line results in light of <a target="_blank" href="https://www.benzinga.com/25/01/43230968/att-q4-earnings-307k-fiber-adds-projects-mid-teens-broadband-growth-in-2025" rel="noreferrer noopener">a solid quarter</a> with strong underlying subscriber metrics.
The analyst noted expectations were modestly elevated given investor positioning but sees fundamentals as de-risked mainly as the company has already provided 2025-27 guidance.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/25/01/43155691/amazon-to-shut-7-quebec-fulfillment-centers-axe-around-2000-jobs" rel="noreferrer noopener">Amazon To Shut 7 Quebec Fulfillment Centers, Axe Around 2,000 Jobs</a>
Investors are concentrated on the broadband market, and any comment on the call regarding the pace of fiber additions, broadband pricing forecast, or changes in the pace of FWA additions could be incremental for the wireless and cable stocks.
AT&amp;T reported revenue of $32.3 billion, which was in line with Schneider&#8217;s estimate of $32.2 billion and the Street&#8217;s estimate of $32.1 billion. Adjusted EBITDA of $10.79 billion was just below Schneider&#8217;s estimate of $10.94 billion and the Street&#8217;s estimate of $10.83 billion. Free cash flow of $4.83 billion was just above Schneider&#8217;s estimate of $4.7 billion and the Street&#8217;s estimate of $4.8 billion.&nbsp;&nbsp;
Wireless service revenue of $16.56 billion was just below Schneider&#8217;s estimate of $16.7 billion but in line with the Street&#8217;s at $16.53 billion. Postpaid phone net adds came in at +482k, well above Schneider&#8217;s estimate of +446k, and the Street&#8217;s at +425k. Wireless EBITDA of $8.89 billion was in line with Schneider&#8217;s estimate of $8.95 billion and the Street&#8217;s at $8.87 billion.&nbsp;&nbsp;
Business wireline service revenue of $4.38 billion was above Schneider&#8217;s estimate of $4.34 billion and the Street&#8217;s estimate of $4.30 billion. In comparison, EBITDA of $1.20 billion was below Schneider&#8217;s estimate of $1.26 billion and the Street&#8217;s estimate of $1.23 billion.
Consumer Wireline revenue of $3.47 billion was in line with Schneider&#8217;s estimate of $3.48 billion and the Street&#8217;s estimate of $3.47 billion.&nbsp;&nbsp;
Broadband revenue was $2.91 billion, versus Schneider&#8217;s estimate of $2.91 billion and the Street&#8217;s estimate of $2.90 billion. Consumer Wireline EBITDA was $1.22 billion, well above Schneider&#8217;s estimate of $1.14 billion and the Street&#8217;s estimate of $1.16 billion.&nbsp;&nbsp;
Fiber net additions of +307k were well above Schneider&#8217;s estimate at +245k and the Street at +259k, while Internet Air net additions of +158k were above GS&#8217;s estimate at +130k and the Street at +134k.
AT&amp;T reiterated its guidance for 2025. Wireless service revenue growth stands at the higher end of 2%-3%, versus Schneider and Street&#8217;s estimate of +2.7%. Fiber broadband revenue growth stands at mid-teens versus Schneider&#8217;s +15.5% and the Street at +16.0%. Adjusted EBITDA growth stands at 3.0% or better versus Schneider&#8217;s at +3.1% and the Street at +2.7%. 
Capital Investment guidance remains at $22 billion versus Schneider at $21.8 billion and the Street at $21.8 billion, free cash flow at $16+ billion versus Schneider at $16.3 billion and the Street at $17.9 billion (not comparable). Adjusted EPS remains at $1.97-$2.07 versus Schneider at $2.04 and the Street at $2.11 (not comparable).
Between Verizon Communications Inc and AT&amp;T, <a target="_blank" href="https://www.benzinga.com/news/earnings/25/01/43189382/verizon-q4-earnings-revenue-beat-1-million-mobile-and-broadband-subscriber-adds-business-segment-margin-expands" rel="noreferrer noopener">postpaid phone net adds</a> are running +1050 Y/Y (relative to the fourth quarter of 2023, when total net adds were +975k Y/Y), which suggests solid trends in the overall wireless market. Also, consumer broadband net additions for AT&amp;T and Verizon are +358k Y/Y (relative to the fourth quarter of 2023, when net additions were +273k) and imply a strengthening market.
Price Action: T stock is up 6.6% at $24.22 at the last check on Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/43139681/himax-to-gain-big-as-tsmc-nvidia-and-amd-advance-silicon-photonics-and-coupe-tech-analyst" target="_blank" rel="noreferrer noopener">Himax To Gain Big As TSMC, Nvidia and AMD Advance Silicon Photonics and COUPE Tech: Analyst</a></li>
</ul>
Photo via Shutterstock.

Price Target

Reiteration

AT&T's Subscriber Momentum And De-Risked Fundamentals Drive Optimism: Goldman Sachs Analyst

General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) will report its fourth-quarter earnings on Tuesday, Jan. 28. Wall Street anticipates earnings of $1.86 per share, with revenues projected at $43.61 billion, as it reports <a href="https://www.benzinga.com/quote/GM/earnings">before the market opens</a>.
The stock is up 52.33% over the past year, 22.11% over the last six months, and 4.94% year-to-date.
<h2 class="wp-block-heading">FTC Investigation, Workforce Restructuring Could Impact Investor Sentiment</h2>
The FTC has taken <a href="https://www.ftc.gov/system/files/ftc_gov/pdf/242_3052_-_general_motors_decisionandorder.pdf">action</a> against GM and OnStar over alleged misuse of driver data, banning them for five years from sharing geolocation and driving behavior information with consumer reporting agencies. While this enforcement does not directly impact GM's core auto business, increased regulatory scrutiny could lead to long-term compliance costs and potential reputational risks.
Additionally, GM is <a href="https://www.cbtnews.com/gm-slashes-more-salaried-jobs-under-new-performance-evaluation-system/">continuing</a> job cuts under a revised performance evaluation system, with terminated employees prohibited from reapplying. While this move is intended to improve efficiency and retain top talent, it could create a high-pressure work environment and raise concerns over employee morale. 
Investors will be watching closely to see if these changes impact GM's operational performance in the coming quarters.
Read Also: <a href="https://www.benzinga.com/25/01/43189554/how-to-earn-500-a-month-from-general-motors-stock-ahead-of-q4-earnings">How To Earn $500 A Month From General Motors Stock Ahead Of Q4 Earnings</a>
<h2 class="wp-block-heading">GM Stock Bullish Ahead Of Q4 Earnings</h2>
Let's take a look at GM stock technicals. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012725&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="630" height="493" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27131312/Screenshot-2025-01-27-at-7.08.35-PM.png" alt="" class="wp-image-751880" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27131312/Screenshot-2025-01-27-at-7.08.35-PM.png 630w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/27131312/Screenshot-2025-01-27-at-7.08.35-PM-300x235.png 300w" sizes="(max-width: 630px) 100vw, 630px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012725&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
The stock is currently trading at $53.91, above its eight, 20 and 50-day moving averages, signaling a bullish trend. The eight and 20-day simple moving averages indicate a bullish short-to-medium term trend, while the 200-day SMA also remains bullish indicating long-term bullish momentum. 
The Moving Average Convergence Divergence (MACD) stands at 0.17, further supporting the bullish outlook. Meanwhile, the Relative Strength Index (RSI) is at 55.52, suggesting neutral momentum.
Despite the bullish technicals, investors should remain cautious of potential selling pressure, which could introduce short-term volatility.
<h2 class="wp-block-heading">GM Analysts See Downside Ahead</h2>
Ratings &amp; Consensus Estimates: The <a href="https://www.benzinga.com/quote/GM/analyst-ratings">consensus analyst rating</a> on GM stock stands at a Buy with a price target of $57.06. Deutsche Bank, UBS and Wells Fargo, who recently rated GM stock, have an average price target of $53, implying a 2.52% downside for the stock.
GM Price Action: Shares of GM were up 0.9% at $54.44 at the time of publication Monday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/asia/25/01/43243584/deepseek-r1-vs-openai-what-consumers-need-to-know-about-ais-latest-challenger">DeepSeek R1 Vs. OpenAI: What Consumers Need To Know About AI&#8217;s Latest Challenger</a></li>
</ul>
Photo: Shutterstock

Technicals

Previews

Tech

GM Faces Regulatory Heat, Bullish Trends Signal Strength Ahead Of Q4

Core Scientific, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) shares are moving lower on Monday amid weakness in Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), which has dropped on overall uncertainty <a href="https://www.benzinga.com/markets/equities/25/01/43221806/nvidia-amd-broadcom-smci-tsmc-and-other-tech-giants-lead-monday-pre-market-selloff-as-nasdaq-100-futures-plummet-over-650-points-amid-reports-of-chinese-ai-startup-deepseek-overtaking-chatgpt">in the market</a>. 
The Details: The uncertainty in Monday&#8217;s market session may stem in part from the introduction of DeepSeek's advanced artificial intelligence (AI) model that has led to declines in stocks across various sectors, including technology, banking and nuclear energy.
The Chinese startup launched its open-source AI platform, DeepSeek R1, which is said to offer capabilities similar to OpenAI's ChatGPT, but at a much lower cost. The R1 model was developed for less than $6 million.
Stocks may be <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43244653/bitcoin-ethereum-solana-crash-heres-why-chinas-low-cost-ai-model-deepseek-may-be-to-blame">falling</a> as investors potentially evaluate the startup's claim of using approximately 50,000 Nvidia H100 GPUs and its implications for American technology companies that have made substantial GPU investments.
Furthermore, the debut of DeepSeek&#8217;s AI platform may also raise concerns about shifts in demand that could impact GPU-heavy industries. This could further contribute to the pullback in crypto-linked stocks like Core Scientific, a company heavily involved in cryptocurrency mining, an activity dependent on GPUs.
As of last check, Bitcoin is trading at around $99,125, per data from <a href="http://Benzinga">Benzinga Pro</a>.
See Also: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43243921/american-express-analysts-expect-gains-from-strong-card-spending">American Express Analysts Expect Gains From Strong Card Spending</a>
CORZ Price Action: At the time of writing, Core shares are moving 30.9% lower at $11.05, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

$BTC

Core Scientific, Inc. - Class A Common Stock

CORZ

What's Going On With Core Scientific Shares Monday?

<a href="https://www.bloomberg.com/news/articles/2025-01-27/activist-pick-for-us-steel-ceo-eyes-major-stake-if-given-top-job" title="https://www.bloomberg.com/news/articles/2025-01-27/activist-pick-for-us-steel-ceo-eyes-major-stake-if-given-top-job">https://www.bloomberg.com/news/articles/2025-01-27/activist-pick-for-us-steel-ceo-eyes-major-stake-if-given-top-job</a>

Management

'Activist Pick For US Steel CEO Eyes Major Stake If Given Top Job; Former Stelco CEO Plans To Take Major Stake To Fix Company; Kestenbaum Says He's Prepared To Become The Top Investor' - Bloomberg News

JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) CEO <a href="https://www.benzinga.com/topic/jamie-dimon">Jamie Dimon</a> indicated that the largest bank in the U.S. "probably would" provide banking services to marijuana businesses if/when federal laws permit.
Dimon&#8217;s comments, made during a recent <a href="https://www.chase.com/business/podcast">episode</a> of the firm&#8217;s podcast, will likely spark optimism within the cannabis industry, which has long struggled with the <a href="https://www.benzinga.com/markets/cannabis/24/08/40629764/financial-roadblocks-in-cannabis-whats-hindering-growth-and-how-to-fix-it-according-to-experts">numerous obstacles</a> of not having access to traditional financial and banking services due to its onerous classification as a <a href="https://www.benzinga.com/topic/controlled-substances-act">Schedule I substance</a>.
<h2 class="wp-block-heading">Debanking? Cannabis Comes To Mind</h2>
What Happened: In response to a comment about debanking made by venture capitalist <a href="https://www.benzinga.com/topic/marc-andreessen">Marc Andreessen </a>on Joe Rogan&#8216;s podcast, Dimon launched into how debanking works at JPMorgan Chase. Apparently, cannabis came to his mind.
"I wanted to explain to him [Marc Andreessen], we have not debanked anyone because of political or religious relationships, period," Dimon said. "Now, when we debank someone, they often blame that reason, but that&#8217;s not a reason. We don&#8217;t bank marijuana companies because there&#8217;s no federal law around it&#8230; If there&#8217;s a federal law, we probably would."
Dimon added that Chase's operations adhere strictly to legal standards to combat issues like money laundering and tax evasion.
"And we do bank some crypto companies and very carefully. We are responsible on the law to fight sex trafficking, money laundering, tax avoidance," Dimon said.
<h2 class="wp-block-heading">Cannabis Banking Reform: Top Of Marijuana Industry&#8217;s Wish List</h2>
The CEO's remarks come as cannabis advocates press for renewed bipartisan momentum on marijuana banking legislation, mainly the <a href="https://www.benzinga.com/topic/safer-banking-act">Secure and Fair Enforcement Regulation </a>(SAFER) Banking Act. Approved by the Senate Banking Committee in <a href="http://Senate Banking Committee">September 2023</a> &#8211; a regulatory milestone that was in the works for nearly a decade &#8211; the bill was crafted to&nbsp;enable legal cannabis businesses access to&nbsp;banks and financial institutions,&nbsp;which<a href="https://www.benzinga.com/markets/cannabis/23/09/34745118/schumer-vows-to-fast-track-newly-revised-cannabis-banking-bill-after-sept-27-vote" target="_blank" rel="noreferrer noopener"> have been off limits</a> for years.&nbsp;&nbsp;
Cannabis rescheduling, a promise repeated on countless occasions during the Biden administration, could result in a situation where banks like Chase would open their doors and welcome the industry&#8217;s <a href="https://www.benzinga.com/markets/cannabis/24/10/41335229/cannabis-industrys-130b-growth-potential-top-states-for-investment-as-financial-institutions-set">billions in earnings</a>. An October 2024 report from Whitney Economics projected that the U.S. cannabis sales are expected to grow from $28.8 billion in 2023 to $87 billion by 2035. Who wouldn&#8217;t want those deposits in their bank?
That said, the cannabis banking bill could now face uncertain prospects in the new GOP-controlled House and Senate. Hence, Dimon's openness on the topic can only be a good thing. 
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/legal/25/01/43219350/elizabeth-warren-to-elon-musk-cut-unnecessary-federal-cannabis-enforcement-and-save-billions">Elizabeth Warren To Elon Musk: Cut Unnecessary Federal Cannabis Enforcement And Save Billions</a></li>
</ul>
Photo: Shutterstock

Cannabis

Legal

Jamie Dimon Says JPMorgan Chase 'Probably Would' Provide Services To Cannabis Industry Once Federal Laws Permit

On Monday, MTR Carbon Capture <a target="_blank" href="https://www.benzinga.com/topic/carbon-emissions" rel="noreferrer noopener">bagged a deal</a> from contract chipmaker Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) to supply a Polaris membrane carbon capture system to treat emissions from a Taiwan Semiconductor solvent incineration facility in Taiwan.
The capture unit will be installed at Taiwan Semiconductor&#8217;s Taichung Zero-Waste Manufacturing Center by the <a target="_blank" href="https://www.businesswire.com/news/home/20250127757815/en/MTR-Carbon-Capture-Selected-to-Provide-a-Capture-Plant-to-TSMC" rel="noreferrer noopener">end of 2025</a>.
The project will showcase the effectiveness of MTR&#8217;s clean membrane capture technology in reducing carbon emissions from Taiwan Semiconductor operations.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/43138590/jim-cramer-says-taiwan-semiconductors-capex-plans-boost-applied-materials-lam-research-kla-stocks" rel="noreferrer noopener">Taiwan Semiconductor&#8217;s Capex Plans Boost These Chip Stocks, Jim Cramer Says</a>
MTR Carbon Capture will deploy larger Polaris systems in the future at additional Taiwan Semiconductor facilities and waste-to-energy plants in the region. MTR is working jointly on this project with CTCI, Taiwan&#8217;s most significant engineering, procurement, and construction (EPC) company.
MTR Carbon Capture President Brett Andrews noted the move as an essential first step in deploying clean Polaris capture systems in Taiwan to help a global leader like Taiwan Semiconductor decarbonize their operations.
Brazil&#8217;s Re.green <a target="_blank" href="https://www.benzinga.com/government/regulations/25/01/43137590/microsoft-invests-in-carbon-credits-to-restore-amazon-rainforest-faces-challenges-from-data-center-growth-trumps-fossil-fuel-focus" rel="noreferrer noopener">reportedly bagged a</a> $200 million deal with Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) to buy 3.5 million carbon credits to restore Amazon and Atlantic forests. In 2023, Microsoft&#8217;s carbon footprint surpassed 17 million tons of carbon dioxide, up 40% from 2020.
Big Tech giants, including Microsoft,&nbsp;Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, and&nbsp;Amazon.com Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) data center endeavors, have pressurized emission control promises.
Amazon founder Jeff Bezos, Microsoft co-founder&nbsp;Bill Gates, and Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) co-founder Jack Ma have been advocates for climate-focused investments.
Price Action:&nbsp;TSM stock is down 13.5% to $191.82 at the last check on Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/43065734/western-digital-poised-for-long-term-growth-despite-short-term-nand-pressures-analysts-say" target="_blank" rel="noreferrer noopener">Western Digital Faces &#8216;Challenging Pricing Environment,&#8217; But There&#8217;s Long-Term Potential: Analysts</a></li>
</ul>
Photo via Shutterstock

AMZN

BABA

GOOG

GOOGL

MSFT

Taiwan Semiconductor Partners with MTR to Tackle Carbon Emissions

Shares of nuclear energy companies, including Nano Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>), Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) and NuScale Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) are trading lower Monday following the emergence of<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43236579/chinas-deepseek-ai-rattles-tech-stocks"> China&#8217;s DeepSeek AI model</a>, which has triggered uncertainty across multiple sectors.
What To Know: DeepSeek's latest large language model (LLM), which has quickly gained traction by surpassing OpenAI's ChatGPT and Meta's Llama 3.1 on Apple's App Store, has sparked fears that AI investments could be redirected. It is pressuring sectors such as nuclear power that depend on technological partnerships and AI-driven optimizations. 
The revelation that DeepSeek built its model in just two months for under $6 million using restricted Nvidia chips has further fueled market unease, prompting a broader sell-off in technology-driven industries, including nuclear energy.
However, Wedbush analyst Dan Ives downplays these concerns, arguing that the sell-off presents a "golden buying opportunity" rather than a legitimate threat to AI investment. Ives asserts that major global enterprises are unlikely to rely on a Chinese startup like DeepSeek for their AI infrastructure needs, meaning long-term demand for advanced AI capabilities—critical to the nuclear energy sector&#8217;s growth and efficiency—remains intact.
Ives emphasizes that the AI sector's focus is on enterprise applications and infrastructure, which are expected to see $2 trillion in capital expenditures over the next three years. He contends that nuclear energy companies leveraging AI technologies for operational improvements, predictive maintenance and safety enhancements will continue to benefit from sustained investments in established AI firms such as Nvidia, Microsoft and Alphabet.
Price Action: Nano Nuclear Energy shares fell 25.7% to $33.14. Oklo shares dropped 28.4% to $29.94. NuScale Power shares declined 29.2% to $19.8 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43244872/tech-stocks-tumble-on-ai-nightmare-nvidia-eyes-worst-day-since-march-2020-bitcoin-drops-below-100000-whats-driving-markets-monday">Tech Stocks Tumble On AI Nightmare, Nvidia Eyes Worst Day Since March 2020, Bitcoin Drops Below $100,000: What&#8217;s Driving Markets Monday?</a></li>
</ul>
Photo: Bigjom Jom via Shutterstock.

OKLO

Nuclear Stocks Are On The Rise Today: What's Going On?

Gladstone Land Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAND#NASDAQ">LAND</a>) ("Gladstone Land" or the "Company") announced that none of its California farms have been impacted by the recent wildfires that have occurred in the southern part of the state. The Company further notes that all of its farms in the state growing permanent crops are insured by the Company or its tenant-farmers under policies that would cover both the crops and any potential loss of crop income.

LAND

Gladstone Land Announces That None Of Its California Farms Have Been Impacted By The Recent Wildfires That Have Occurred In The Southern Part Of The State

Pool's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/POOL#NYSE">POOL</a>) short percent of float has fallen 7.79% since its last report. The company recently reported that it has 2.89 million shares sold short, which is 8.88% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.86 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Pool Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738006222_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Pool has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Pool's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Pool's peer group average for short interest as a percentage of float is 5.39%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

POOL

How Is The Market Feeling About Pool?

eBay's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBAY#NYSE">EBAY</a>) short percent of float has fallen 9.82% since its last report. The company recently reported that it has 18.87 million shares sold short, which is 4.5% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.31 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>eBay Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738006217_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for eBay has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing eBay's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, eBay's peer group average for short interest as a percentage of float is 9.58%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

EBAY

(EBAY) - Analyzing eBay's Short Interest

Elevance Health's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) short percent of float has risen 5.37% since its last report. The company recently reported that it has 3.63 million shares sold short, which is 1.57% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.98 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Elevance Health Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738006211_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Elevance Health has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Elevance Health's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Elevance Health's peer group average for short interest as a percentage of float is 5.53%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

How Is The Market Feeling About Elevance Health?

On Saturday, Pfizer Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) revealed results from the Phase 3 BREAKWATER trial evaluating Braftovi&nbsp;(encorafenib) in combination with cetuximab (marketed as Erbitux) and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) in patients with metastatic colorectal cancer (mCRC) with <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43216973/pfizers-braftovi-combination-regimen-demonstrates-improved-response-in-patients-with-braf-v600e-mu" rel="noreferrer noopener">a&nbsp;</a><a target="_blank" href="https://www.benzinga.com/quote/PFE" rel="noreferrer noopener">BRAF V600E</a><a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43216973/pfizers-braftovi-combination-regimen-demonstrates-improved-response-in-patients-with-braf-v600e-mu" rel="noreferrer noopener"> mutation</a>.
At the time of this analysis, the Braftovi combination regimen demonstrated a clinically meaningful and statistically significant improvement in confirmed objective response rate (ORR) compared to patients receiving chemotherapy with or without bevacizumab <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43216973/pfizers-braftovi-combination-regimen-demonstrates-improved-response-in-patients-with-braf-v600e-mu" rel="noreferrer noopener">(60.9% vs. 40.0%)</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42986202/pfizer-eyes-20-billion-revenue-from-acquisitions-amid-patent-cliff-challenges" rel="noreferrer noopener">Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent Cliff Challenges</a>
The results were presented at the 2025 American Society of Clinical Oncology Gastrointestinal Cancer Symposium (ASCO GI) and were simultaneously published in&nbsp;<a target="_blank" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41591-024-03443-3&amp;esheet=54190707&amp;newsitemid=20250124736884&amp;lan=en-US&amp;anchor=Nature+Medicine&amp;index=2&amp;md5=e34d314000d7a0319df057ab6633d8e1" rel="noreferrer noopener">Nature Medicine</a>.
The estimated median duration of response was 13.9 months with Braftovi plus cetuximab and mFOLFOX6 and 11.1 months with chemotherapy with or without bevacizumab.
Of patients on Braftovi plus cetuximab and mFOLFOX6, 22.4% (n=15) had a response lasting 12 months or longer, compared to 11.4% (n=5) with chemotherapy with or without bevacizumab.
The median time to response was 7.1 weeks with Braftovi plus cetuximab and mFOLFOX6 and 7.3 weeks with chemotherapy with or without bevacizumab.
Overall survival (OS) data were immature during this analysis but demonstrated a trend favoring Braftovi plus cetuximab and mFOLFOX6 compared to patients receiving chemotherapy with or without bevacizumab.
Median overall survival with Braftovi plus cetuximab with chemotherapy was not estimable, and 14.6 months with chemotherapy with or without bevacizumab.
The BREAKWATER trial is ongoing for OS and progression-free survival (PFS), with PFS results expected in 2025.
The safety profile of Braftovi in combination with cetuximab and mFOLFOX6 in the BREAKWATER trial was consistent with the known safety profile of each respective agent. No new safety signals were identified.
In December 2024, the FDA granted accelerated approval to Braftovi in combination with cetuximab and mFOLFOX6 for BRAF&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42626814/u-s-fda-approves-pfizers-braftovi-combination-regimen-as-first-line-treatment-of-braf-v600e-mutant" rel="noreferrer noopener">V600E</a><a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42626814/u-s-fda-approves-pfizers-braftovi-combination-regimen-as-first-line-treatment-of-braf-v600e-mutant" rel="noreferrer noopener">-mutant mCRC</a>.
Price Action: PFE stock is up 2.76% at $26.81 at the last check on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/43237532/veru-shares-tumble-despite-enobosarms-lean-muscle-preservation-breakthrough" target="_blank" rel="noreferrer noopener">Veru Shares Tumble Despite Enobosarm&#8217;s Lean Muscle Preservation Breakthrough</a></li>
</ul>
Image via Shutterstock

Pfizer's Conditionally Approved Braftovi Combo Therapy Regime Shows Improved Response In Colorectal Cancer Patients

<a href="https://storage.courtlistener.com/recap/gov.uscourts.mad.270018/gov.uscourts.mad.270018.64.0.pdf" title="https://storage.courtlistener.com/recap/gov.uscourts.mad.270018/gov.uscourts.mad.270018.64.0.pdf">https://storage.courtlistener.com/recap/gov.uscourts.mad.270018/gov.uscourts.mad.270018.64.0.pdf</a>

IRBT

Class Action Lawsuit Against iRobot Has Been Dismissed With Prejudice

The Federal Reserve's first meeting of 2025 comes at a moment of elevated uncertainty, as a brutal tech sell-off erased trillions in market value and fresh tensions between President Donald Trump and Fed Chair Jerome Powell may threaten to shake interest rate policy <a href="https://www.benzinga.com/topic/interest-rates">in the months ahead.</a>
Tech stocks took a massive hit at the start of the week, driven by concerns over China&#8217;s DeepSeek, an open-source AI model that reportedly rivals top U.S. models at a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43239042/magnificent-seven-broadcom-lose-nearly-900-billion-in-value-as-deepseek-sparks-ai-carnage-why-this-expert-is-still-bullish-on-us-tech">fraction of the cost. </a>
The reaction was swift and severe. The VIX index, also known as market fear gauge, soared 25% on Monday with Wall Street shedding over $1.2 trillion in market capitalization. NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) tumbled 16%, erasing nearly $500 billion in value.
Despite the market chaos, it&#8217;s a done deal the Fed expected to keep interest rates unchanged at 4.25%-4.50% after three consecutive cuts totaling 100 basis points last year, giving investors no room to hope for a miracle. 
Yet, the real focus will be on Powell's messaging, whether he signals that further cuts are coming or if the central bank will hold firm in its inflation fight despite political interference from Washington. 
Trump has a history of pushing for lower interest rates, clashing with Powell during his first term over monetary policy. Now, with inflation moderating, the president appears ready to pressure the Fed again.
<h1 class="wp-block-heading">How Many Interest-Rate Cuts In 2025?</h1>
At its last meeting in December, the Fed projected only two rate cuts in 2025, revising earlier expectations of four. 
Policymakers also raised their inflation forecast for headline Personal Consumption Expenditures to 2.5%, up from 2.1% in September. Core PCE inflation, which excludes volatile food and energy prices, is now seen at 2.5% in 2025, up from 2.2% earlier.
Investors will be watching closely to see if Powell acknowledges recent benign inflation reports, which some argue could justify a more dovish stance. 
Goldman Sachs economist David Mericle highlighted in a note Monday that &#8220;in the press conference, we will listen for hints about whether the further decline in inflation we expect in coming months could open the door to rate cuts.&#8221;
<h1 class="wp-block-heading">Trump vs. Powell: A New Round In The Interest Rate Fight?</h1>
This week's Fed meeting will be the first since Trump returned to the White House, and tensions between the president and Powell are already heating up.
During a video speech at the <a href="https://www.benzinga.com/news/global/25/01/43170854/trump-outlines-economic-reset-at-davos-5-things-you-need-to-know">World Economic Forum last Thursday</a>, Trump made his stance on interest rates clear: "With oil prices going down, I&#8217;ll demand that interest rates drop immediately, and likewise, they should be dropping all over the world.&#8221;
Journalists will likely press Powell on whether Trump's remarks influence policy decisions, but the Fed chair has consistently emphasized the central bank's independence.
Yet, speculation is already swirling about whether Trump could try to remove Powell before his term expires in May 2026. 
According to Kalshi, a CFTC-regulated betting market, there is a 21% chance Powell will be out as Fed chair by the end of the year.
<iframe loading="lazy" style="border: 0;" src="https://kalshi.com/external-widgets/events/LEAVEPOWELL-25/markets/LEAVEPOWELL-25-DEC31?color_scheme=light&amp;widget_size=large" width="552px" height="400px"></iframe>
A pressing issue is the potential impact of Trump's trade policies on inflation. Goldman Sachs estimated last week that new tariffs could add up to one percentage point to inflation if they <a href="https://www.benzinga.com/25/01/43193866/trumps-tariff-hikes-could-stoke-consumer-inflation-jitters-challenge-fed-goldman-sachs-warns">significantly influence consumer expectations.</a> That could complicate the Fed's decision-making, forcing policymakers to balance inflation risks with economic growth concerns.
Beyond interest rates and inflation, another potential Trump-Powell clash could emerge over digital assets. 
The president signed last week an executive order aimed at strengthening U.S. leadership in digital assets, which some speculate could lay the groundwork for a Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) strategic reserve later this year.
Powell, however, remains firmly opposed to Bitcoin as a central bank asset. "We&#8217;re not allowed to own Bitcoin," he said in December, stressing that the Federal Reserve Act <a href="https://www.benzinga.com/news/econ-s/24/12/42564807/powell-triggers-market-carnage-vix-spikes-58-stocks-plummet-dollar-hits-2-year-highs-bitcoin-nosedives">prohibits such holdings. </a>
"People use Bitcoin as a speculative asset… It's just like gold, only it's virtual, it's digital," he also added. 
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43203417/dollar-cracks-below-50-day-moving-average-as-trumps-tariff-trade-unwinds-buy-the-rumor-sell-the-fact">Dollar Cracks Below 50-Day Moving Average As Trump&#8217;s Tariff Trade Unwinds: &#8216;Buy The Rumor, Sell The Fact&#8217;</a></li>
</ul>
Photo: Shutterstock

Macro Economic Events

Politics

Econ #s

Economics

Federal Reserve

NVDA

Traders Want The Fed To Tame Market Volatility, Yet Trump-Powell Interest Rate Fight Is Just Beginning

VSME

VS Media SG To Acquire 21% Stake In S T Meng For 1.5M Class A Shares

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) analyst Mark Delaney highlights the Model Y update, automotive market share, what consumers are saying in a new survey and key questions ahead of the company's fourth quarter earnings report on <a href="https://www.benzinga.com/earnings">Wednesday, Jan. 29.</a>
Tesla Model Y: The refreshed Model Y, which comes to the U.S. and Europe after a launch in China earlier this month, offers good upgrades, Goldman Sachs analyst Delaney said in the investor note.
The analyst maintained a Neutral rating with a price target of $345.
"Some of the changes made in the refresh, beyond the extended range, include updated exterior lighting, an added screen for the back seat, ambient lighting, and better outside noise reduction," Delaney said.
The analyst said a new camera on the front bumper could better assist with parking and also could be used for Autopilot and FSD. &nbsp;
Tesla is offering discounts on Model Y units in inventory ahead of the refresh launch in March.
"Mix and how fast Tesla ramps up production of the refreshed version will help determine the effect on blended ASPs. We believe the new version offers several good enhancements."
Read Also: <a href="https://www.benzinga.com/news/global/25/01/43172806/tesla-lost-15-billion-in-brand-value-in-2024-report-says-did-elon-musks-political-push-hurt-ev-giant">Tesla Lost $15 Billion In Brand Value In 2024, Report Says: Did Elon Musk&#8217;s Political Push Hurt EV Giant?</a>
Tesla Market Share: The analyst estimates Tesla's sales in the U.S. were flat in the fourth quarter on a year-over-year basis. Tesla's market share for the electric vehicle sector in the U.S. likely hit "the mid 40% range," Delaney said. This would be down from around 50% in the fourth quarter of 2023.
Delaney estimates Tesla's sales in the European market were down 10% year-over-year in the fourth quarter and its market share went from 16% in last year's fourth quarter to 13% in this most recent fourth quarter.
The analyst said Tesla's sales in China are estimated up 16% year-over-year in the fourth quarter and the company had a high-single-digit percentage market share for battery-powered electric vehicles.
Consumer Feedback Survey: Delaney uses data from a HundredX consumer feedback survey to predict Tesla's demand.
"The survey data still shows a decline for Tesla in the brand/trust metric, whereas the score for the broader industry have been relatively stable. Similarly, Tesla's net purchase intent scores have declined by more than the peer group," Delaney said.
The analyst said items like new vehicles and Full Self Driving are keys in potentially reversing the Tesla scores going forward.
Key Items to Watch: Ahead of Tesla's fourth-quarter financial results, Delaney highlights the top items to watch.
These are the analyst&#8217;s key topics for the earnings report:
<ol>
<li>Automotive non-GAAP gross margins</li>
<li>Vehicle delivery outlook for 2025</li>
<li>Progress with FSD and AI-related efforts</li>
<li>Growth in other segments, including Services and Energy</li>
<li>Progress with Optimus and expectations on ramp timing</li>
</ol>
"We believe a key debate in the market will be whether Tesla can grow more meaningfully in 2025/2026, driven by a refreshed Model Y and a new lower-cost model or models," Delaney said.
The analyst said Tesla is targeting 20% to 30% year-over-year growth in deliveries in 2025.
Delaney said the potential end of the $7,500 federal tax credit for electric vehicles could be a key topic in the company commentary.
On the AI front, Delaney said Tesla is unlikely to hit a goal of being safer than human drivers in the second quarter of 2025. The analyst also questions Tesla's timeline launch of the Cybercab robotaxi in 2026.
"We expect Tesla to begin very limited robotaxi operations in 2H26."
TSLA Price Action: Tesla stock is down 3.02% to $394.62 on Monday versus a 52-week trading range of $138.80 to $488.54. Tesla stock is up about 110% over the past year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42856115/tesla-analyst-on-high-stakes-future-optimus-robotaxi-fsd-have-potential-but-execution-risks-loom">Tesla Analyst On High-Stakes Future: Optimus, Robotaxi, FSD Have Potential, But Execution Risks Loom</a></li>
</ul>
Photo: Shutterstock

TSLA

Tesla Analyst's Top 5 Items To Watch In Q4 Earnings: Will Refreshed Model Y, New EVs Help Growth?

Deep-pocketed investors have adopted a bearish approach towards Pinterest (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in PINS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Pinterest. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 27% leaning bullish and 45% bearish. Among these notable options, 3 are puts, totaling $107,666, and 8 are calls, amounting to $725,015.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $25.0 to $50.0 for Pinterest during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Pinterest's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Pinterest's substantial trades, within a strike price spectrum from $25.0 to $50.0 over the preceding 30 days.
<h3>Pinterest 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738005326_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PINS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.97</td>
<td>$1.6</td>
<td>$1.68</td>
<td>$35.00</td>
<td>$178.1K</td>
<td>5.2K</td>
<td>1.0K</td>
</tr>
<tr>
<td>PINS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$1.17</td>
<td>$1.14</td>
<td>$1.17</td>
<td>$37.00</td>
<td>$172.0K</td>
<td>998</td>
<td>1.4K</td>
</tr>
<tr>
<td>PINS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$1.83</td>
<td>$1.7</td>
<td>$1.7</td>
<td>$35.00</td>
<td>$129.2K</td>
<td>5.2K</td>
<td>1.8K</td>
</tr>
<tr>
<td>PINS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$1.74</td>
<td>$1.7</td>
<td>$1.74</td>
<td>$35.00</td>
<td>$91.1K</td>
<td>5.2K</td>
<td>1.6K</td>
</tr>
<tr>
<td>PINS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$0.44</td>
<td>$0.42</td>
<td>$0.43</td>
<td>$32.50</td>
<td>$44.1K</td>
<td>4.1K</td>
<td>225</td>
</tr>
</tbody>
</table>

<h3>About Pinterest</h3>
Pinterest is a social media platform with a focus on product and idea discovery. Pinterest users, or pinners, can leverage the platform as they go about gathering ideas on topics such as home improvement, fashion, cooking, and travel. The company has more than 500 million monthly active users, two thirds of whom are female. Pinterest generates revenue by selling digital ads on its platform. While the platform's user base spans the globe, the vast majority of its revenue stems from ads shown to North American users.
After a thorough review of the options trading surrounding Pinterest, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Pinterest</h3>
<ul>
<li>With a volume of 4,328,891, the price of PINS is up 0.91% at $33.2. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 10 days.</li>
</ul>
<h3>What Analysts Are Saying About Pinterest</h3>
A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $36.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Pinterest with a target price of $36. 
&#x2A; An analyst from Jefferies has revised its rating downward to Hold, adjusting the price target to $32. 
&#x2A; An analyst from Keybanc persists with their Overweight rating on Pinterest, maintaining a target price of $37. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Pinterest, which currently sits at a price target of $39. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Pinterest, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Government Trades

Merck KGaA

top performing MKKGY trades

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga